Theriva Biologics Stock Alpha and Beta Analysis
| TOVX Stock | USD 1.44 0.10 7.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Theriva Biologics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Theriva Biologics over a specified time horizon. Remember, high Theriva Biologics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Theriva Biologics' market risk premium analysis include:
Beta 1.47 | Alpha (0.70) | Risk 11.82 | Sharpe Ratio (0.08) | Expected Return (1.00) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Theriva |
Theriva Biologics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Theriva Biologics market risk premium is the additional return an investor will receive from holding Theriva Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Theriva Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Theriva Biologics' performance over market.| α | -0.7 | β | 1.47 |
Theriva Biologics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Theriva Biologics' Buy-and-hold return. Our buy-and-hold chart shows how Theriva Biologics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Theriva Biologics Market Price Analysis
Market price analysis indicators help investors to evaluate how Theriva Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theriva Biologics shares will generate the highest return on investment. By understating and applying Theriva Biologics stock market price indicators, traders can identify Theriva Biologics position entry and exit signals to maximize returns.
Theriva Biologics Return and Market Media
The median price of Theriva Biologics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 1.56 with a coefficient of variation of 51.74. The daily time series for the period is distributed with a sample standard deviation of 1.16, arithmetic mean of 2.24, and mean deviation of 0.98. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Synapse Trading Down 2.4 percent This Week | 09/16/2024 |
2 | Walmart Expands Centers of Excellence Benefit To Include All Cancers | 10/04/2024 |
3 | Blue Shield of California, Salesforce Partner to Modernize Prior Authorization | 10/22/2024 |
4 | Theriva Biologics seleccionada como finalista en el concurso internacional para las becas del programa Advance Biotech Grant en la regin EMEA de Merck KGaA | 11/01/2024 |
5 | WTW Theres A Disconnect Between Employers and Employees on Wellbeing Programs | 11/06/2024 |
6 | 4 Things Employers Should Know About Psychedelic Medicines | 11/08/2024 |
7 | Fort Health Secures 5.5M to Expand Access to Integrated Pediatric Mental Health Care | 11/12/2024 |
8 | Theriva Biologics presenta los aspectos operativos ms destacados y los resultados financieros del tercer trimestre de 2024 | 11/13/2024 |
9 | Telehealth Advocates Praise DEAs 3rd Extension of Telemedicine Flexibilities, but Call for Further Action | 11/19/2024 |
10 | Why the DOJs Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere | 11/21/2024 |
11 | Cortica Snags 80M to Make Autism Care for Children Less Fragmented | 11/25/2024 |
12 | Health Leaders Applaud Bidens Proposal to Expand MedicareMedicaid Coverage for Anti-Obesity Medications | 11/27/2024 |
About Theriva Biologics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Theriva or other stocks. Alpha measures the amount that position in Theriva Biologics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 (projected) | Current Ratio | 19.37 | 6.45 | 4.07 | Net Debt To EBITDA | 4.64 | 1.86 | 1.06 |
Theriva Biologics Upcoming Company Events
As portrayed in its financial statements, the presentation of Theriva Biologics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Theriva Biologics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Theriva Biologics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Theriva Biologics. Please utilize our Beneish M Score to check the likelihood of Theriva Biologics' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Theriva Biologics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.